• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Serum lactate dehydrogenase level may predict acute respiratory distress syndrome of patients with fever infected by SARS-CoV-2.

作者信息

Zhou Yang, Ding Ning, Yang Guifang, Peng Wen, Tang Fengning, Guo Cuirong, Chai Xiangping

机构信息

Department of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha, China.

Emergency Medicine and Difficult Disease Institute, Second Xiangya Hospital, Central South University, Changsha, China.

出版信息

Ann Transl Med. 2020 Sep;8(17):1118. doi: 10.21037/atm-20-2411.

DOI:10.21037/atm-20-2411
PMID:33145337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7575930/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4163/7575930/f2b41f703a59/atm-08-17-1118-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4163/7575930/8031a171089d/atm-08-17-1118-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4163/7575930/f2b41f703a59/atm-08-17-1118-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4163/7575930/8031a171089d/atm-08-17-1118-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4163/7575930/f2b41f703a59/atm-08-17-1118-f2.jpg

相似文献

1
Serum lactate dehydrogenase level may predict acute respiratory distress syndrome of patients with fever infected by SARS-CoV-2.血清乳酸脱氢酶水平可能预测感染新型冠状病毒肺炎的发热患者发生急性呼吸窘迫综合征。
Ann Transl Med. 2020 Sep;8(17):1118. doi: 10.21037/atm-20-2411.
2
Association between obesity and clinical prognosis in patients infected with SARS-CoV-2.肥胖与 SARS-CoV-2 感染患者临床预后的关系。
Infect Dis Poverty. 2020 Jun 29;9(1):80. doi: 10.1186/s40249-020-00703-5.
3
Characteristics and Outcomes of Children With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Admitted to a Quaternary Hospital: A Single-Center Experience.一家四级医院收治的感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）儿童的特征与结局：单中心经验
Cureus. 2024 Jan 18;16(1):e52532. doi: 10.7759/cureus.52532. eCollection 2024 Jan.
4
Biomarkers of acute respiratory distress syndrome in adults hospitalised for severe SARS-CoV-2 infection in Tenerife Island, Spain.西班牙特内里费岛因严重SARS-CoV-2感染住院的成人急性呼吸窘迫综合征生物标志物
BMC Res Notes. 2020 Dec 9;13(1):555. doi: 10.1186/s13104-020-05402-w.
5
Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever.严重急性呼吸综合征相对于发热起病的临床和实验室特征。
Chest. 2004 Aug;126(2):509-17. doi: 10.1378/chest.126.2.509.
6
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Febrile Infants Without Respiratory Distress.无呼吸窘迫的发热婴儿中的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染
Clin Infect Dis. 2020 Nov 19;71(16):2243-2245. doi: 10.1093/cid/ciaa452.
7
Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.巴西原住民中由严重急性呼吸综合征冠状病毒2感染或其他病原体引起的严重急性呼吸综合征：一项关于冠状病毒病（COVID）-19大流行第一年的观察性研究。
Lancet Reg Health Am. 2022 Apr;8:100177. doi: 10.1016/j.lana.2021.100177. Epub 2022 Jan 7.
8
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
9
The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial.CHARTER-Ireland 试验：在爱尔兰，雾化肝素能否减少需要高级呼吸支持的 SARS-CoV-2 患者的急性肺损伤：一项随机对照试验的研究方案和统计分析计划。
Trials. 2022 Sep 14;23(1):774. doi: 10.1186/s13063-022-06518-z.
10
Combination of C21 and ARBs with rhACE2 as a therapeutic protocol: A new promising approach for treating ARDS in patients with coronavirus infection.将C21、血管紧张素受体阻滞剂与重组人血管紧张素转换酶2联合作为治疗方案：一种治疗冠状病毒感染患者急性呼吸窘迫综合征的新的有前景的方法。
Med J Islam Repub Iran. 2020 Sep 14;34:120. doi: 10.34171/mjiri.34.120. eCollection 2020.

引用本文的文献

1
Serum Total Antioxidant Capacity (TAC) and TAC/Lymphocyte Ratio as Promising Predictive Markers in COVID-19.血清总抗氧化能力（TAC）和 TAC/淋巴细胞比值作为 COVID-19 有前途的预测标志物。
Int J Mol Sci. 2023 Aug 18;24(16):12935. doi: 10.3390/ijms241612935.
2
COVID-19 Biomarkers Comparison: Children, Adults and Elders.COVID-19 生物标志物比较：儿童、成人和老年人。
Medicina (Kaunas). 2023 May 3;59(5):877. doi: 10.3390/medicina59050877.
3
Risk of Acute Respiratory Distress Syndrome in Community-Acquired Pneumonia Patients: Use of an Artificial Neural Network Model.

本文引用的文献

1
Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.炎症小体和细胞焦亡作为 COVID-19 的治疗靶点。
J Immunol. 2020 Jul 15;205(2):307-312. doi: 10.4049/jimmunol.2000513. Epub 2020 Jun 3.
2
Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China.COVID-19 患者的肝损伤：来自中国武汉市单个中心的 115 例回顾性分析。
Liver Int. 2020 Sep;40(9):2095-2103. doi: 10.1111/liv.14455. Epub 2020 Apr 28.
3
The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients.
社区获得性肺炎患者发生急性呼吸窘迫综合征的风险：人工神经网络模型的应用
Emerg Med Int. 2023 Feb 7;2023:2631779. doi: 10.1155/2023/2631779. eCollection 2023.
4
COVID-19 Inflammatory Markers and Vitamin D Relationship in Pediatric Patients.儿科患者中 COVID-19 炎症标志物与维生素 D 的关系
Life (Basel). 2022 Dec 28;13(1):91. doi: 10.3390/life13010091.
5
Hypo- and Hyperphosphatemia at Admission as Independent Factors of Mortality of COVID-19 Patients: Findings from a Retrospective Cohort Study.入院时低磷血症和高磷血症作为COVID-19患者死亡的独立因素：一项回顾性队列研究的结果
Int J Endocrinol Metab. 2022 Jul 12;20(3):e126386. doi: 10.5812/ijem-126386. eCollection 2022 Jul.
6
Hemolytic anemia in COVID-19.COVID-19 相关溶血性贫血。
Ann Hematol. 2022 Sep;101(9):1887-1895. doi: 10.1007/s00277-022-04907-7. Epub 2022 Jul 8.
7
Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent.SARS-CoV-2 感染中的炎症小体和白细胞介素-1 家族细胞因子：从预后标志物到治疗药物。
Cytokine. 2022 Sep;157:155934. doi: 10.1016/j.cyto.2022.155934. Epub 2022 Jun 7.
8
Clinical features, laboratory characteristics and risk factors for mortality of COVID-19 patients in a secondary hospital in Oman during the first wave of the SARS-CoV-2 pandemic.阿曼一家二级医院在SARS-CoV-2大流行第一波期间COVID-19患者的临床特征、实验室特征及死亡风险因素
Bull Natl Res Cent. 2022;46(1):139. doi: 10.1186/s42269-022-00825-w. Epub 2022 May 16.
9
Role of Polypeptide Inflammatory Biomarkers in the Diagnosis and Monitoring of COVID-19.多肽炎症生物标志物在新型冠状病毒肺炎诊断和监测中的作用
Int J Pept Res Ther. 2022;28(2):59. doi: 10.1007/s10989-022-10366-5. Epub 2022 Jan 24.
10
Determination role of some biomarkers tests for severe SARS-COV-2 infections in babylon province/IRAQ.伊拉克巴比伦省严重新冠病毒感染的一些生物标志物检测的判定作用
Mater Today Proc. 2022;61:686-689. doi: 10.1016/j.matpr.2021.08.225. Epub 2021 Aug 28.
94 例新冠肺炎出院患者病毒清除与生化结局的相关性。
Inflamm Res. 2020 Jun;69(6):599-606. doi: 10.1007/s00011-020-01342-0. Epub 2020 Mar 29.
4
A Comparative Study on the Clinical Features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias.新型冠状病毒肺炎与其他肺炎的临床特征比较研究。
Clin Infect Dis. 2020 Jul 28;71(15):756-761. doi: 10.1093/cid/ciaa247.
5
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak.基于 RNA 的宏基因组二代测序（mNGS）方法从 2019 年武汉暴发的两例肺炎个体病例中鉴定出一种新型人类冠状病毒。
Emerg Microbes Infect. 2020 Feb 5;9(1):313-319. doi: 10.1080/22221751.2020.1725399. eCollection 2020.
6
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
7
Lactate dehydrogenase as a prognostic marker of renal transplant recipients with severe community-acquired pneumonia: a 10-year retrospective study.乳酸脱氢酶作为重症社区获得性肺炎肾移植受者的预后标志物：一项10年回顾性研究
Ann Transl Med. 2019 Nov;7(22):660. doi: 10.21037/atm.2019.10.75.
8
Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation.乳酸脱氢酶及其同工酶作为肺损伤或炎症指标的效用。
Eur Respir J. 1996 Aug;9(8):1736-42. doi: 10.1183/09031936.96.09081736.